Characterization of a broadly specific cadaverine N-hydroxylase involved in desferrioxamine B biosynthesis in Streptomyces sviceus.
Bacterial Proteins
/ metabolism
Biocatalysis
Cadaverine
/ metabolism
Catalytic Domain
Deferoxamine
/ metabolism
Dinitrocresols
/ metabolism
Flavin-Adenine Dinucleotide
/ metabolism
Flavins
/ metabolism
Holoenzymes
/ metabolism
Hydroxylation
Kinetics
Mixed Function Oxygenases
/ biosynthesis
NADP
/ metabolism
Ornithine
/ metabolism
Oxidation-Reduction
Siderophores
/ biosynthesis
Streptomyces
/ enzymology
Journal
PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081
Informations de publication
Date de publication:
2021
2021
Historique:
received:
08
01
2021
accepted:
26
02
2021
entrez:
30
3
2021
pubmed:
31
3
2021
medline:
14
10
2021
Statut:
epublish
Résumé
N-hydroxylating flavin-dependent monooxygenases (FMOs) are involved in the biosynthesis of hydroxamate siderophores, playing a key role in microbial virulence. Herein, we report the first structural and kinetic characterization of a novel alkyl diamine N-hydroxylase DesB from Streptomyces sviceus (SsDesB). This enzyme catalyzes the first committed step in the biosynthesis of desferrioxamine B, a clinical drug used to treat iron overload disorders. X-ray crystal structures of the SsDesB holoenzyme with FAD and the ternary complex with bound NADP+ were solved at 2.86 Å and 2.37 Å resolution, respectively, providing a structural view of the active site environment. SsDesB crystallized as a tetramer and the structure of the individual protomers closely resembles the structures of homologous N-hydroxylating FMOs from Erwinia amylovora (DfoA), Pseudomonas aeruginosa (PvdA), and Aspergillus fumigatus (SidA). Using NADPH oxidation, oxygen consumption, and product formation assays, kinetic parameters were determined for various substrates with SsDesB. SsDesB exhibited typical saturation kinetics with substrate inhibition at high concentrations of NAD(P)H as well as cadaverine. The apparent kcat values for NADPH in steady-state NADPH oxidation and oxygen consumption assays were 0.28 ± 0.01 s-1 and 0.24 ± 0.01 s-1, respectively. However, in product formation assays used to measure the rate of N-hydroxylation, the apparent kcat for NADPH (0.034 ± 0.008 s-1) was almost 10-fold lower under saturating FAD and cadaverine concentrations, reflecting an uncoupled reaction, and the apparent NADPH KM was 33 ± 24 μM. Under saturating FAD and NADPH concentrations, the apparent kcat and KM for cadaverine in Csaky assays were 0.048 ± 0.004 s-1 and 19 ± 9 μM, respectively. SsDesB also N-hydroxylated putrescine, spermidine, and L-lysine substrates but not alkyl (di)amines that were branched or had fewer than four methylene units in an alkyl chain. These data demonstrate that SsDesB has wider substrate scope compared to other well-studied ornithine and lysine N-hydroxylases, making it an amenable biocatalyst for the production of desferrioxamine B, derivatives, and other N-substituted products.
Identifiants
pubmed: 33784308
doi: 10.1371/journal.pone.0248385
pii: PONE-D-21-00796
pmc: PMC8009421
doi:
Substances chimiques
Bacterial Proteins
0
Dinitrocresols
0
Flavins
0
Holoenzymes
0
Siderophores
0
Flavin-Adenine Dinucleotide
146-14-5
4,6-dinitro-o-cresol
1604ZJR09T
NADP
53-59-8
Ornithine
E524N2IXA3
Mixed Function Oxygenases
EC 1.-
lysine monooxygenase
EC 1.13.12.2
Deferoxamine
J06Y7MXW4D
Cadaverine
L90BEN6OLL
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, N.I.H., Intramural
Research Support, U.S. Gov't, Non-P.H.S.
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0248385Subventions
Organisme : NIGMS NIH HHS
ID : P20 GM103449
Pays : United States
Organisme : Intramural NIH HHS
ID : ZIC BC011016
Pays : United States
Organisme : NCI NIH HHS
ID : HHSN261200800001E
Pays : United States
Organisme : CCR NIH HHS
ID : HHSN261200800001C
Pays : United States
Organisme : Intramural NIH HHS
ID : ZIA BC010341
Pays : United States
Déclaration de conflit d'intérêts
G.T.L is affiliated with and received support in the form of salary from The Frederick National Laboratory for Cancer Research, which is funded by the federal government and operated by Leidos Biomedical Research, Inc. This does not alter our adherence to all the PLOS ONE policies on sharing data and materials.
Références
J Bacteriol. 2006 Oct;188(20):7205-10
pubmed: 17015659
Biochemistry. 2010 Sep 21;49(37):8033-42
pubmed: 20704181
Int J Hematol Oncol Stem Cell Res. 2016 Oct 1;10(4):239-247
pubmed: 27928480
Bioinformatics. 2007 Mar 15;23(6):717-23
pubmed: 17242029
Arch Biochem Biophys. 2015 Nov 1;585:25-31
pubmed: 26375201
J Biol Chem. 2015 May 15;290(20):12676-88
pubmed: 25802330
Biochemistry. 2010 Aug 10;49(31):6777-83
pubmed: 20614882
Biotechnol J. 2020 Jul;15(7):e1900451
pubmed: 32170807
Biochemistry. 2009 May 26;48(20):4371-6
pubmed: 19368334
Protein Sci. 2018 Jan;27(1):293-315
pubmed: 29067766
Acta Crystallogr D Biol Crystallogr. 2004 Dec;60(Pt 12 Pt 1):2256-68
pubmed: 15572779
Mini Rev Med Chem. 2013 Jul;13(9):1311-26
pubmed: 23701657
Nat Prod Rep. 2009 Nov;26(11):1362-84
pubmed: 19844637
Gene. 1988 Apr 29;64(2):179-88
pubmed: 2841191
Mol Microbiol. 2012 Oct;86(2):485-99
pubmed: 22906379
J Am Chem Soc. 2004 Dec 22;126(50):16282-3
pubmed: 15600304
Chem Biodivers. 2012 Sep;9(9):1880-90
pubmed: 22976977
Bioorg Chem. 2011 Dec;39(5-6):171-7
pubmed: 21871647
Infect Immun. 2005 Sep;73(9):5493-503
pubmed: 16113265
Biochemistry. 2011 Oct 4;50(39):8489-96
pubmed: 21870809
Acta Crystallogr D Biol Crystallogr. 2009 Oct;65(Pt 10):1074-80
pubmed: 19770504
Biochemistry. 2007 Oct 23;46(42):11930-7
pubmed: 17900176
Chembiochem. 2012 May 7;13(7):972-6
pubmed: 22522643
ACS Chem Biol. 2018 Jan 19;13(1):11-25
pubmed: 29182270
J Mol Biol. 1973 May 15;76(2):241-56
pubmed: 4737475
J Bacteriol. 1996 Aug;178(16):4877-84
pubmed: 8759851
Philos Trans R Soc Lond B Biol Sci. 2018 Jun 5;373(1748):
pubmed: 29685972
Microbiology (Reading). 2006 Nov;152(Pt 11):3355-3366
pubmed: 17074905
Clin Transl Imaging. 2017;5(1):15-27
pubmed: 28138436
Biochemistry. 2014 Sep 30;53(38):6063-77
pubmed: 25184411
IUCrJ. 2014 May 30;1(Pt 4):213-20
pubmed: 25075342
Appl Microbiol Biotechnol. 2020 Aug;104(15):6481-6499
pubmed: 32504128
J Biotechnol. 2006 Aug 5;124(4):670-89
pubmed: 16712999
Arch Biochem Biophys. 2010 Jan 1;493(1):26-36
pubmed: 19944667
Protein Sci. 2003 Sep;12(9):1865-71
pubmed: 12930986
Genet Med. 2010 Feb;12(2):61-76
pubmed: 20098328
Acta Crystallogr D Biol Crystallogr. 2010 Apr;66(Pt 4):486-501
pubmed: 20383002
ACS Chem Biol. 2016 May 20;11(5):1452-62
pubmed: 27004785
J Struct Biol. 2018 Jun;202(3):236-249
pubmed: 29428557
Acta Crystallogr D Biol Crystallogr. 2014 Jun;70(Pt 6):1579-88
pubmed: 24914969
ACS Chem Biol. 2016 Oct 21;11(10):2782-2789
pubmed: 27541336
Acta Crystallogr D Biol Crystallogr. 2012 Apr;68(Pt 4):352-67
pubmed: 22505256
Acta Crystallogr D Biol Crystallogr. 2006 Aug;62(Pt 8):859-66
pubmed: 16855301
J Appl Crystallogr. 2007 Aug 1;40(Pt 4):658-674
pubmed: 19461840
J Mol Biol. 1968 Apr 28;33(2):491-7
pubmed: 5700707
Biochemistry. 2012 Sep 11;51(36):7043-5
pubmed: 22928747
Infect Immun. 2016 Jul 21;84(8):2324-2335
pubmed: 27271740